Tenaya Therapeutics (TNYA) USD0.0001
Tenaya Therapeutics, Inc. is a preclinical stage biotechnology company. The Company is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing a pipeline of disease-modifying therapies developed using its product platforms and capabilities to target defined sub-populations of patients with rare or other prevalent forms of heart disease. The Company is advancing product candidates from three diverse product platforms, such as gene therapy, cellular regeneration, and precision medicine. It is also advancing a diverse pipeline that includes both gene therapies and small molecules. The Company’s capabilities include disease models, capsid engineering, promoters and regulatory elements, drug delivery and manufacturing.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.